News Headlines Article

Gene test may aid early-stage lung cancer patients
San Francisco Chronicle

In a finding that could improve the survival odds for early-stage lung cancer patients, UCSF researchers have determined a new molecular test can predict more accurately than current diagnostic methods which tumors are more likely to be aggressive and turn deadly. The study results, published Thursday in the medical journal The Lancet, come from the two largest clinical trials ever conducted on the molecular genetics of lung cancer and included early-stage patients from Northern California Kaiser hospitals as well as from China.